Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLCHEAVEY, Susan; O'BYRNE, Kenneth J; GATELY, Kathy et al.Cancer treatment reviews. 2014, Vol 40, Num 3, pp 445-456, issn 0305-7372, 12 p.Article

Clinico-pathological and biological prognostic factors in pleural malignant mesotheliomaO'BYRNE, Kenneth J; EDWARDS, John G; WALLER, David A et al.Lung cancer. 2004, Vol 45, pp S45-S48, issn 0169-5002, SUP1Article

Ipilimumab-induced Immune-related Renal Failure ― A Case ReportFORDE, Patrick M; ROCK, Kathy; WILSON, Graham et al.Anticancer research. 2012, Vol 32, Num 10, pp 4607-4608, issn 0250-7005, 2 p.Article

IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGFBAIRD, Anne-Marie; GRAY, Steven G; O'BYRNE, Kenneth J et al.European journal of cancer (1990). 2011, Vol 47, Num 12, pp 1908-1918, issn 0959-8049, 11 p.Article

Activation of p38 MAP kinase by asbestos in rat mesothelial cells is mediated by oxidative stressSWAIN, William A; O'BYRNE, Kenneth J; FAUX, Stephen P et al.American journal of physiology. Lung cellular and molecular physiology. 2004, Vol 30, Num 4, pp 859-865, issn 1040-0605, 7 p.Article

Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancerWELSH, Tomas J; GREEN, Ruth H; RICHARDSON, Donna et al.Journal of clinical oncology. 2005, Vol 23, Num 35, pp 8959-8967, issn 0732-183X, 9 p.Article

Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancerCOX, Giles; JONES, J. Louise; ANDI, Allan et al.Lung cancer. 2001, Vol 34, Num 3, pp 417-426, issn 0169-5002Article

The role of DNA repair pathways in cisplatin resistant lung cancerO'GRADY, Shane; FINNA, Stephen P; CUFFE, Sinead et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1161-1170, issn 0305-7372, 10 p.Article

Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in Malignant mesotheliomaEDWARDS, John G; SWINSON, Daniel E. B; JONES, J. Louise et al.Chest. 2003, Vol 124, Num 5, pp 1916-1923, issn 0012-3692, 8 p.Article

A Phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesisBRAYBROOKE, Jeremy P; O'BYRNE, Kenneth J; SMITH, Kenneth et al.Clinical cancer research. 2000, Vol 6, Num 12, pp 4697-4704, issn 1078-0432Article

Angiogenesis and the immune response as targets for the prevention and treatment of colorectal cancerSHARMA, Ricky A; DALGLEISH, Angus G; STEWARD, William P et al.Oncology reports. 2003, Vol 10, Num 5, pp 1625-1631, issn 1021-335X, 7 p.Article

Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapyRICHARDSON, C. M; SHARMA, R. A; COX, G et al.Lung cancer. 2003, Vol 39, Num 1, pp 1-13, issn 0169-5002, 13 p.Article

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancerBAIRD, Anne-Marie; LEONARD, Jennifer; NAICKER, Krisha M et al.Lung cancer. 2013, Vol 79, Num 1, pp 83-90, issn 0169-5002, 8 p.Article

Prostacyclin Synthase Expression and Epigenetic Regulation in Nonsmall Cell Lung CancerCATHCART, Mary-Clare; GRAY, Steven G; BAIRD, Anne-Marie et al.Cancer. 2011, Vol 117, Num 22, pp 5121-5132, issn 0008-543X, 12 p.Article

Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancerSHAH, Amit; SWAIN, William A; RICHARDSON, Donna et al.Clinical cancer research. 2005, Vol 11, Num 8, pp 2930-2936, issn 1078-0432, 7 p.Article

Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liverSHARMA, Ricky A; EATOCK, Martin M; TWELVES, Christopher J et al.Cancer chemotherapy and pharmacology. 2001, Vol 48, Num 3, pp 197-201, issn 0344-5704Article

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung CancerSHAW, Alice T; KIM, Dong-Wan; WU, Yi-Long et al.The New England journal of medicine. 2013, Vol 368, Num 25, pp 2385-2394, issn 0028-4793, 10 p.Article

Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancerDOWLING, Paul; CLARKE, Colin; CLYNES, Martin et al.International journal of cancer (Print). 2012, Vol 131, Num 4, pp 911-923, issn 0020-7136, 13 p.Article

BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesotheliomaBUSACCA, Sara; SHEAF, Michael; QUINN, Jennifer E et al.Journal of pathology (Print). 2012, Vol 227, Num 2, pp 200-208, issn 0022-3417, 9 p.Article

Regulation of EP receptors in non-small cell lung cancer by epigenetic modificationsGRAY, Steven G; AL-SARRAF, Nael; BAIRD, Anne-Marie et al.European journal of cancer (1990). 2009, Vol 45, Num 17, pp 3087-3097, issn 0959-8049, 11 p.Article

The effect of extent of local resection on patterns of disease progression in malignant pleural mesotheliomaSTEWART, Duncan J; MARTIN-UCAR, Antonio; PILLING, John E et al.The Annals of thoracic surgery. 2004, Vol 78, Num 1, pp 245-252, issn 0003-4975, 8 p.Article

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancerPUJOL, Jean-Louis; PIRKER, Robert; VON HEYDEBRECK, Anja et al.Lung cancer. 2014, Vol 83, Num 2, pp 211-218, issn 0169-5002, 8 p.Article

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancerO'FLAHERTY, John D; GRAY, Steven; RICHARD, Derek et al.Lung cancer. 2012, Vol 76, Num 1, pp 19-25, issn 0169-5002, 7 p.Article

Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesotheliomaBLAYNEY, Jaine K; CERESOLI, Giovanni L; MUTTI, Luciano et al.European journal of cancer (1990). 2012, Vol 48, Num 16, pp 2983-2992, issn 0959-8049, 10 p.Article

Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non-small-cell lung cancerO'BYRNE, Kenneth J; DANSON, Sarah; DUNLOP, David et al.Journal of clinical oncology. 2007, Vol 25, Num 22, pp 3266-3273, issn 0732-183X, 8 p.Article